Literature DB >> 24026344

Improved antibody production in Chinese hamster ovary cells by ATF4 overexpression.

Ahmad M Haredy1, Akitoshi Nishizawa, Kohsuke Honda, Tomoshi Ohya, Hisao Ohtake, Takeshi Omasa.   

Abstract

To improve antibody production in Chinese hamster ovary (CHO) cells, the humanized antibody-producing CHO DP-12-SF cell line was transfected with the gene encoding activating transcription factor 4 (ATF4), a central factor in the unfolded protein response. Overexpression of ATF4 significantly enhanced the production of antibody in the CHO DP-12-SF cell line. The specific IgG production rate of in the ATF4-overexpressing CHO-ATF4-16 cells was approximately 2.4 times that of the parental host cell line. Clone CHO-ATF4-16 did not show any change in growth rate compared with the parental cells or mock-transfected CHO-DP12-SF cells. The expression levels of mRNAs encoding both the antibody heavy and light chains in the CHO-ATF4-16 clone were analyzed. This analysis showed that ATF4 overexpression improved the total production and specific production rate of antibody without affecting the mRNA transcription level. These results indicate that ATF4 overexpression is a promising method for improving recombinant IgG production in CHO cells.

Entities:  

Year:  2013        PMID: 24026344      PMCID: PMC3853642          DOI: 10.1007/s10616-013-9631-x

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  41 in total

1.  Molecular definition of predictive indicators of stable protein expression in recombinant NS0 myeloma cells.

Authors:  Louise M Barnes; Catherine M Bentley; Alan J Dickson
Journal:  Biotechnol Bioeng       Date:  2004-01-20       Impact factor: 4.530

Review 2.  Economic aspects of commercial manufacture of biopharmaceuticals.

Authors:  Rolf G Werner
Journal:  J Biotechnol       Date:  2004-09-30       Impact factor: 3.307

Review 3.  Production of recombinant protein therapeutics in cultivated mammalian cells.

Authors:  Florian M Wurm
Journal:  Nat Biotechnol       Date:  2004-11       Impact factor: 54.908

4.  Overexpression of GADD34 enhances production of recombinant human antithrombin III in Chinese hamster ovary cells.

Authors:  Takeshi Omasa; Takashi Takami; Tomoshi Ohya; Eriko Kiyama; Tetsuji Hayashi; Hiroko Nishii; Hideo Miki; Kaoru Kobayashi; Kohsuke Honda; Hisao Ohtake
Journal:  J Biosci Bioeng       Date:  2008-12       Impact factor: 2.894

5.  Optimized signal peptides for the development of high expressing CHO cell lines.

Authors:  Lars Kober; Christoph Zehe; Juergen Bode
Journal:  Biotechnol Bioeng       Date:  2013-01-17       Impact factor: 4.530

6.  Rapid construction of transgene-amplified CHO cell lines by cell cycle checkpoint engineering.

Authors:  Kyoung Ho Lee; Masayoshi Onitsuka; Kohsuke Honda; Hisao Ohtake; Takeshi Omasa
Journal:  Appl Microbiol Biotechnol       Date:  2013-04-25       Impact factor: 4.813

7.  J chain synthesis and secretion of hexameric IgM is differentially regulated by lipopolysaccharide and interleukin 5.

Authors:  T D Randall; R M Parkhouse; R B Corley
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-01       Impact factor: 11.205

Review 8.  Oxidative folding: cellular strategies for dealing with the resultant equimolar production of reactive oxygen species.

Authors:  Yuichiro Shimizu; Linda M Hendershot
Journal:  Antioxid Redox Signal       Date:  2009-09       Impact factor: 8.401

Review 9.  Recent advances in technology supporting biopharmaceutical production from mammalian cells.

Authors:  M Butler; A Meneses-Acosta
Journal:  Appl Microbiol Biotechnol       Date:  2012-10-05       Impact factor: 4.813

10.  Engineering of chaperone systems and of the unfolded protein response.

Authors:  Saeed U Khan; Martin Schröder
Journal:  Cytotechnology       Date:  2008-08-15       Impact factor: 2.058

View more
  7 in total

1.  Enhanced IgG1 production by overexpression of nuclear factor kappa B inhibitor zeta (NFKBIZ) in Chinese hamster ovary cells.

Authors:  Masayoshi Onitsuka; Yukie Kinoshita; Akitoshi Nishizawa; Tomomi Tsutsui; Takeshi Omasa
Journal:  Cytotechnology       Date:  2017-11-29       Impact factor: 2.058

2.  Zinc supplementation increases protein titer of recombinant CHO cells.

Authors:  Berta Capella Roca; Antonio Alarcón Miguez; Joanne Keenan; Srinivas Suda; Niall Barron; Donal O'Gorman; Padraig Doolan; Martin Clynes
Journal:  Cytotechnology       Date:  2019-08-08       Impact factor: 2.058

Review 3.  N-Glycan-based ER Molecular Chaperone and Protein Quality Control System: The Calnexin Binding Cycle.

Authors:  Lydia Lamriben; Jill B Graham; Benjamin M Adams; Daniel N Hebert
Journal:  Traffic       Date:  2016-01-10       Impact factor: 6.215

Review 4.  Oxidative stress-alleviating strategies to improve recombinant protein production in CHO cells.

Authors:  Valentine Chevallier; Mikael Rørdam Andersen; Laetitia Malphettes
Journal:  Biotechnol Bioeng       Date:  2019-12-20       Impact factor: 4.530

5.  Harnessing secretory pathway differences between HEK293 and CHO to rescue production of difficult to express proteins.

Authors:  Magdalena Malm; Chih-Chung Kuo; Mona Moradi Barzadd; Aman Mebrahtu; Num Wistbacka; Ronia Razavi; Anna-Luisa Volk; Magnus Lundqvist; David Kotol; Hanna Tegel; Sophia Hober; Fredrik Edfors; Torbjörn Gräslund; Veronique Chotteau; Ray Field; Paul G Varley; Robert G Roth; Nathan E Lewis; Diane Hatton; Johan Rockberg
Journal:  Metab Eng       Date:  2022-03-14       Impact factor: 8.829

6.  Violacein improves recombinant IgG production by controlling the cell cycle of Chinese hamster ovary cells.

Authors:  Masahide Kido; Hideaki Idogaki; Kouji Nishikawa; Takeshi Omasa
Journal:  Cytotechnology       Date:  2020-11-23       Impact factor: 2.040

7.  Overexpression of transcription factor Foxa1 and target genes remediate therapeutic protein production bottlenecks in Chinese hamster ovary cells.

Authors:  Audrey Berger; Valérie Le Fourn; Jacqueline Masternak; Alexandre Regamey; Iris Bodenmann; Pierre-Alain Girod; Nicolas Mermod
Journal:  Biotechnol Bioeng       Date:  2020-02-23       Impact factor: 4.530

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.